share_log

Intuitive Surgical (NASDAQ:ISRG) Receives New Coverage From Analysts at William Blair

Intuitive Surgical (NASDAQ:ISRG) Receives New Coverage From Analysts at William Blair

Intuitive Surgical(纳斯达克股票代码:ISRG)获得威廉·布莱尔分析师的新报道
Financial News Live ·  2023/03/23 20:35

Equities research analysts at William Blair initiated coverage on shares of Intuitive Surgical (NASDAQ:ISRG – Get Rating) in a report released on Thursday, The Fly reports. The brokerage set an "outperform" rating on the medical equipment provider's stock.

威廉·布莱尔的股票研究分析师开始报道以下股票 Intuitive Surgical(纳斯达克:ISRG — 获取评级) The Fly报道,在周四发布的一份报告中。该经纪公司对医疗设备提供商的股票设定了 “跑赢大盘” 的评级。

A number of other analysts also recently issued reports on ISRG. Barclays lifted their target price on Intuitive Surgical from $235.00 to $298.00 in a research report on Wednesday, January 4th. StockNews.com started coverage on Intuitive Surgical in a research report on Thursday, March 16th. They set a "hold" rating on the stock. Argus boosted their price target on Intuitive Surgical from $265.00 to $320.00 and gave the stock a "buy" rating in a research report on Thursday, December 22nd. Mizuho lowered their price target on Intuitive Surgical from $245.00 to $240.00 in a research report on Wednesday, January 25th. Finally, BTIG Research lowered their price target on Intuitive Surgical from $316.00 to $279.00 and set a "buy" rating on the stock in a research report on Wednesday, January 25th. Six analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $273.83.

其他一些分析师最近也发布了有关ISRG的报告。巴克莱银行在1月4日星期三的一份研究报告中将Intuitive Surgical的目标价格从235.00美元上调至298.00美元。StockNews.com在3月16日星期四的一份研究报告中开始报道Intuitive Surgical。他们对该股设定了 “持有” 评级。阿格斯在12月22日星期四的一份研究报告中将Intuitive Surgical的目标股价从265.00美元上调至320.00美元,并将该股评为 “买入”。瑞穗在1月25日星期三的一份研究报告中将Intuitive Surgical的目标股价从245.00美元下调至240.00美元。最后,BTIG Research在1月25日星期三的一份研究报告中将Intuitive Surgical的目标股价从316.00美元下调至279.00美元,并对该股设定了 “买入” 评级。六位分析师对该股进行了持有评级,十三位分析师对该股给予了买入评级。根据Marketbeat.com的数据,Intuitive Surgical目前的平均评级为 “适度买入”,共识目标价为273.83美元。

Get
获取
Intuitive Surgical
直观外科
alerts:
警报:

Intuitive Surgical Stock Performance

直观的手术股表现

NASDAQ:ISRG opened at $240.81 on Thursday. The stock's 50-day simple moving average is $242.81 and its 200 day simple moving average is $239.16. The company has a market cap of $84.35 billion, a P/E ratio of 65.80, a P/E/G ratio of 4.79 and a beta of 1.29. Intuitive Surgical has a 52-week low of $180.07 and a 52-week high of $308.97.

纳斯达克股票代码:ISRG周四开盘价为240.81美元。该股的50天简单移动平均线为242.81美元,其200天简单移动平均线为239.16美元。该公司的市值为843.5亿美元,市盈率为65.80,市盈率为4.79,beta为1.29。Intuitive Surgical创下52周低点180.07美元,52周高点为308.97美元。

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last released its earnings results on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.25 by ($0.02). The company had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.66 billion. Intuitive Surgical had a net margin of 21.25% and a return on equity of 11.27%. Intuitive Surgical's revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.30 EPS. As a group, equities analysts predict that Intuitive Surgical will post 4.21 earnings per share for the current fiscal year.

Intuitive Surgical(纳斯达克股票代码:ISRG — 获取评级)最后一次发布财报是在1月24日星期二。这家医疗设备提供商公布了本季度每股收益(EPS)1.23美元,比分析师普遍预期的1.25美元(0.02美元)高出1.25美元。该公司在本季度的收入为16.6亿美元,而分析师的估计为16.6亿美元。Intuitive Surgical的净利润率为21.25%,股本回报率为11.27%。Intuitive Surgical的收入与去年同期相比增长了6.7%。去年同期,该公司公布的每股收益为1.30美元。作为一个整体,股票分析师预测,Intuitive Surgical将在本财年公布每股收益4.21美元。

Insider Activity at Intuitive Surgical

直觉外科的内部活动

In related news, EVP David J. Rosa sold 45,025 shares of the business's stock in a transaction that occurred on Monday, February 6th. The stock was sold at an average price of $250.53, for a total value of $11,280,113.25. Following the completion of the sale, the executive vice president now directly owns 125,385 shares in the company, valued at $31,412,704.05. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, VP Fredrik Widman sold 116 shares of the business's stock in a transaction that occurred on Thursday, February 16th. The stock was sold at an average price of $240.77, for a total value of $27,929.32. Following the completion of the sale, the vice president now directly owns 1,605 shares in the company, valued at $386,435.85. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP David J. Rosa sold 45,025 shares of the business's stock in a transaction that occurred on Monday, February 6th. The shares were sold at an average price of $250.53, for a total transaction of $11,280,113.25. Following the transaction, the executive vice president now owns 125,385 shares of the company's stock, valued at $31,412,704.05. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 82,396 shares of company stock worth $20,438,478. Company insiders own 0.90% of the company's stock.

在相关新闻中,执行副总裁戴维·罗莎在2月6日星期一进行的一笔交易中出售了该公司的45,025股股票。该股的平均售价为250.53美元,总价值为11,280,113.25美元。出售完成后,执行副总裁现在直接拥有该公司的125,385股股票,价值31,412,704.05美元。此次出售是在向美国证券交易委员会提交的文件中披露的,该文件可在 这个链接。在相关新闻中,副总裁弗雷德里克·威德曼在2月16日星期四进行的一笔交易中出售了该公司的116股股票。该股的平均售价为240.77美元,总价值为27,929.32美元。出售完成后,副总裁现在直接拥有该公司的1,605股股份,价值386,435.85美元。此次出售是在向美国证券交易委员会提交的文件中披露的,该文件可在 这个链接。此外,执行副总裁戴维·罗莎在2月6日星期一进行的一笔交易中出售了该公司的45,025股股票。这些股票的平均价格为250.53美元,总交易额为11,280,113.25美元。交易完成后,执行副总裁现在拥有该公司125,385股股票,价值31,412,704.05美元。可以找到本次出售的披露信息 这里。在过去的九十天里,内部人士出售了价值20,438,478美元的82,396股公司股票。公司内部人士拥有该公司0.90%的股票。

Institutional Inflows and Outflows

机构流入和流出

Several institutional investors have recently added to or reduced their stakes in ISRG. RB Capital Management LLC raised its position in Intuitive Surgical by 4.4% during the first quarter. RB Capital Management LLC now owns 1,735 shares of the medical equipment provider's stock valued at $523,000 after purchasing an additional 73 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in Intuitive Surgical by 0.6% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 946,709 shares of the medical equipment provider's stock valued at $285,603,000 after purchasing an additional 5,233 shares in the last quarter. Baird Financial Group Inc. raised its position in Intuitive Surgical by 2.3% during the first quarter. Baird Financial Group Inc. now owns 21,089 shares of the medical equipment provider's stock valued at $6,362,000 after purchasing an additional 481 shares in the last quarter. Brown Brothers Harriman & Co. raised its position in Intuitive Surgical by 576.7% during the first quarter. Brown Brothers Harriman & Co. now owns 406 shares of the medical equipment provider's stock valued at $122,000 after purchasing an additional 346 shares in the last quarter. Finally, Covestor Ltd raised its position in Intuitive Surgical by 50.4% during the first quarter. Covestor Ltd now owns 418 shares of the medical equipment provider's stock valued at $126,000 after purchasing an additional 140 shares in the last quarter. 81.96% of the stock is currently owned by institutional investors and hedge funds.

一些机构投资者最近增加了或减少了在ISRG的股份。RB Capital Management LLC在第一季度将其在Intuitive Surgical的头寸提高了RB Capital Management LLC在上个季度又购买了73股股票后,现在拥有这家医疗设备提供商的1,735股股票,价值52.3万美元。未来资产全球投资有限公司Ltd. 在第一季度将其在Intuitive Surgical的头寸提高了0.6%。未来资产全球投资有限公司Ltd. 在上个季度又购买了5,233股股票后,现在拥有这家医疗设备提供商的946,709股股票,价值285,603,000美元。贝尔德金融集团公司在第一季度将其在Intuitive Surgical的头寸提高了2.3%。贝尔德金融集团公司在上个季度又购买了481股股票后,现在拥有这家医疗设备提供商的21,089股股票,价值6,362,000美元。Brown Brothers Harriman & Co. 在第一季度将其在Intuitive Surgical的头寸提高了576.7%。Brown Brothers Harriman & Co. 在上个季度又购买了346股股票后,现在拥有这家医疗设备提供商的406股股票,价值12.2万美元。最后,Covestor Ltd在第一季度将其在Intuitive Surgical的排名提高了50.4%。Covestor Ltd在上个季度又购买了140股股票后,现在拥有这家医疗设备提供商的418股股票,价值12.6万美元。81.96%的股票目前由机构投资者和对冲基金持有。

Intuitive Surgical Company Profile

直觉外科公司简介

(Get Rating)

(获取评级)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.

Intuitive Surgical, Inc通过全面的产品和服务生态系统提供机器人辅助手术解决方案和侵入性护理。其产品包括达芬奇外科和离子腔内系统。该公司由 Frederic H. Moll、John Gordon Freund 和 Robert G.

Further Reading

进一步阅读

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • Why Wall Street Loves These 3 Penny Stocks
  • Low Volume Bunge Plunge Presents an Opportunity
  • Carvana May Be Able To Reach Profitability This Year
  • 3 Leading Dividend Stocks Expected To Grow Earnings
  • Are Homebuilders Ready To Rally If Fed Rate Hikes Slow?
  • 免费获取 StockNews.com 关于 Intuitive Surgical (ISRG) 的研究报告
  • 为什么华尔街喜欢这三只细价股
  • 低音量蹦极跳提供了机会
  • Carvana 今年可能能够实现盈利
  • 3只主要股息股票有望增加收益
  • 如果美联储加息缓慢,房屋建筑商准备好反弹了吗?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

接收《直觉外科日报》的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Intuitive Surgical及相关公司的最新新闻和分析师评级的简明每日摘要。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发